stockrowAMNEAL PHARMACEUTICALS, INC. (AMRX) vs Liquidia Corporation (LQDA)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.41 −2.71%
- Liquidia Corporation LQDA 44.69 −5.68%
AMNEAL PHARMACEUTICALS, INC. and Liquidia Corporation are both Drug Manufacturers Specialty & Generic companies. AMNEAL PHARMACEUTICALS, INC. is the larger, with a market value of $6.8B against $4.0B — 1.7× the size. Liquidia Corporation trades at the lower P/E: 28.5× against 36.9×. Liquidia Corporation grew revenue faster over the last twelve months: 2,233.7% against 8.88%. Liquidia Corporation has the higher net margin (30.7% vs 4.17%) and the higher return on invested capital (121.1% vs 8.45%). Across the 21 metrics below, Liquidia Corporation leads on 17 and AMNEAL PHARMACEUTICALS, INC. on 4.
Valuation
Profitability
| Metric | AMRX | LQDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.24% | 92.54% | 53.51% |
| Operating margin | 14.99% | 37.39% | 0.00% |
| Net margin | 4.17% | 30.74% | (2.45%) |
| Free cash flow margin | (1.89%) | 33.42% | 0.00% |
| Return on equity | (53,107.17%) | 131.82% | (0.80%) |
| Return on assets | 3.01% | 35.57% | (1.67%) |
| Return on invested capital | 8.45% | 121.05% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack